Characteristics | Frequency | |||
---|---|---|---|---|
(n = 788) | Year of diagnosis | p-value | ||
< 2012 | > 2012 | |||
Age at diagnosis (years) | ||||
Mean (±SD) | 62 (±7.6) | 61.4 (±7.2) | 61.7 (±7.8) | |
Median (IQR) | 63 (57–67) | 63 (57–63) | 62 (56–67) | |
Age at diagnosis (years) | 0.86 | |||
n (%) | ||||
≤ 65 | 496 (62.9) | 289 (64.1) | 207 (64.7) | |
> 65 | 275 (34.9) | 162 (35.9) | 113 (35.3) | |
< 50 | 59 (7.5) | – | – | |
50–59 | 219 (27.7) | – | – | |
60–69 | 374 (47.3) | – | – | |
70–80 | 119 (15.0) | – | – | |
Unrecorded | 17 (2.2) | – | – | |
Year of Diagnosis | n (%) | 457 (58.0) | 331 (42.0) | – |
< 2009 | 107 (13.5) | – | – | |
2009–2011 | 261 (33.0) | – | – | |
2012–2014 | 296 (37.4) | – | – | |
2015–2018 | 124 (15.7) | – | – | |
Ethnicity | n (%) | n = 669 | 0.04 | |
Caucasian | 472 (59.7) | 319 (74.2) | 152 (63.6) | |
Black African | 107 (13.5) | 59 (13.7) | 48 (20.1) | |
Black Caribbean | 69 (8.6) | 40 (9.3) | 29 (12.1) | |
Asian | 22 (2.8) | 12 (2.8) | 10 (4.2) | |
Unrecorded | 119 (15.1) | – | – | |
PSA level | (ng/mL) | 0.001 | ||
Mean (±SD) | 6.6 (± 3.4) | 6.4 (±3.3) | 6.9 (±3.5) | |
Median (IQR) | 6 (4.4–8.0) | 6.0 (4.0–8.7) | 6.29 (4.7–8.2) | |
PSA level (ng/mL) | n (%) | n = 718 | 0.09 | |
0–5 | 273 (34.6) | 173 (40.8) | 100 (34.0) | |
5 .1–10 | 350 (44.4) | 193 (45.5) | 157 (53.4) | |
10.1–15 | 74 (9.4) | 48 (11.3) | 26 (8.8) | |
15.1–20 | 21 (2.7) | 10 (2.4) | 11 (3.7) | |
Unrecorded | 70 (8.9) | – | – | |
T Stage (at DRE) | n (%) | |||
Benign | 331 (42.0) | – | – | |
T2 | 176 (22.3) | – | – | |
Number having a diagnostic MRI | n (%) | 0.001 | ||
MRI at diagnosis | 235 (29.8) | 64 (14.0) | 171 (51.7) | |
Unrecorded | 553 (70.2) | 393 (86.0) | 160 (48.3) | |
Diagnostic MRI T Stage | n = 235 | – | ||
n (%) | ||||
T0 | 24 (10.2) | – | – | |
T2 | 135 (57.4) | – | – | |
Unrecorded | 76 (32.3) | – | – | |
Method of diagnostic biopsy | n (%) | n = 708 | 0.12 | |
TP | 254 (32.2) | 141 (33.6) | 113 (39.2) | |
TRUS | 422 (53.6) | 263 (62.6) | 159 (55.2) | |
Othera | 32 (4.1) | 16 (3.8) | 16 (5.6) | |
Unrecorded | 80 (10.2) | – | – | |
Gleason Score | n (%) | n = 730 | 0.75 | |
≤ 3 + 3 | 595 (75.5) | 357 (81.9) | 238 (81.0) | |
3 + 4 | 135 (17.1) | 79 (18.1) | 56 (19.1) | |
Unrecorded | 58 (7.4) | – | – | |
Number of cores taken | ||||
Mean (±SD) | 21.0 (±10.7) | – | – | |
Median (IQR) | 15 (12–32) | – | – | |
Number of cores taken | ||||
n (%) | n = 564 | 0.08 | ||
< 12 | 37 (4.7) | 19 (5.6) | 18 (6.8) | |
12–14 | 266 (33.8) | 141 (41.3) | 125 (47.0) | |
15–24 | 80 (10.2) | 49 (14.4)) | 31 (11.7) | |
> 25 | 224 (28.4) | 132 (38.4) | 92 (34.6 | |
Unrecorded | 181 (23.0) | – | – | |
Number of positive cores | ||||
Mean (±SD) | 2.3 (±2.1) | – | – | |
Median (IQR) | 2 (1–3) | – | – | |
Number of positive cores | n (%) | n = 611 | 0.02 | |
1 | 288 (36.6) | 178 (52.4) | 110 (40.6) | |
2 | 129 (16.4) | 64 (18.8) | 65 (22.9) | |
3 | 76 (9.6) | 64 (12.4) | 34 (12.6) | |
> 3 | 118 (15.0) | 56 (16.5) | 62 (22.9) | |
Unrecorded | 177 (22.5) | – | – |